Tim is CEO of Sample6. Tim previously served as CEO of Vela Systems, a quality management software company, which was acquired by Autodesk in June 2012. Prior to joining Vela, Tim served as CEO of Eleven Technology, the leader in next generation field applications for the food and beverage industry, which was acquired by Trimble Navigation in 2006. Prior to Eleven, Tim spent five years as the number two executive of I-many, an enterprise contract management software company that went public during his tenure. Prior to I-many, Tim spent eight years with Accenture and a year with EMC Corporation. Tim holds a BS in Chemical Engineering from Case Western Reserve University and an MBA from the University of Chicago.

Mike runs operations and manufacturing at Sample6 Technologies. Prior to Sample6, Mike worked at Flagship Ventures in Cambridge, as well as KPMG Consulting and McKinsey & Company in Germany. Mike co-developed Sample6’s technology working with Dr Tim Lu during his doctoral work on Systems and Synthetic Biology in the Lab of Professor Jim Collins. He is also visiting scholar with the Howard Hughes Medical Institute in the Biomedical Engineering Department at Boston University and the Synthetic Biology Group at MIT. Prior to his doctoral degree, Mike graduated with a M.S. in Biochemistry from the Free University of Berlin, and was a recipient of the German Academic Exchange Fellowship (DAAD) to study at MIT.

Ed runs product and engineering at Sanple6. Prior to Sample6, Ed was VP of Engineering at Brontes Technologies (acquired by 3M in 2006), Brontes developed a real-time, hand-held 3D imaging system, integrating multiple technologies, for use by dentists. Over 100,000 cases have been completed, the system is available in the US and Europe. Prior to Brontes, Ed was VP of Engineering for Zmed, Inc. (acquired by Varian Medical Systems in 2003). Ed led the development of 3D ultrasound for patient positioning in radiotherapy, with systems in use in the US and Japan and over 50,000 patient treated. Prior to Zmed, Ed helped launch Alchemy 3D, acquired by SynaPix in 1999. Alchemy developed pioneering 3D scene reconstruction software for film and television. Ed received his BS in CS from Columbia University and his MS in CS from Tufts University. Ed is a technical adviser to XL Hybrids, Inc., a hybrid vehicle startup and serves on the Coulter Grant Oversight Committee at Boston University.

Tim was one of the initial inventors of Sample6 Technologies’ core platform and is a co-founder and Board Member of the company. In addition to his role at Sample6, Tim is also an assistant professor at MIT in the Synthetic Biology group as well as an associate fellow at the Broad Institute. He was selected as one of 35 young innovators under 35 by MIT's Technology Review, as well as awarded the 2008 Lemelson-MIT Student Prize and the 2008 National Inventors Hall of Fame Collegiate Inventors Competition Grand Prize for his work on engineered bacteriophage for the treatment of intractable bacterial infections. Tim graduated from MIT with an SB and an M.Eng. in Electrical Engineering and Computer Science and with a PhD from the Harvard-MIT Health Sciences and Technology Program in Electrical and Biomedical Engineering while receiving his doctoral training under Jim Collins at BU. Tim also has his M.D. from Harvard Medical School.